Envestnet Asset Management Inc Guardant Health, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 13,680 shares of GH stock, worth $431,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,680

Previous 11,488 19.08%

Holding current value

$431,877

Previous $331,000 5.44%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$22.3 - $36.29 $48,881 - $79,547	2,192 Added 19.08%	13,680 $313,000
Q2 2024 Aug 08, 2024	SELL	$16.07 - $31.84 $331,941 - $657,687	-20,656 Reduced 64.26%	11,488 $331,000
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $2.21 Million - $3.47 Million	-128,836 Reduced 80.03%	32,144 $663,000
Q4 2023 Feb 13, 2024	SELL	$21.58 - $29.5 $210,491 - $287,743	-9,754 Reduced 5.71%	160,980 $4.35 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $2.94 Million - $4.56 Million	114,128 Added 201.62%	170,734 $5.06 Million
Q2 2023 Aug 04, 2023	BUY	$20.94 - $38.01 $204,960 - $372,041	9,788 Added 20.91%	56,606 $2.03 Million
Q1 2023 May 11, 2023	SELL	$22.92 - $33.76 $9,443 - $13,909	-412 Reduced 0.87%	46,818 $1.1 Million
Q4 2022 Feb 07, 2023	SELL	$25.44 - $59.78 $299,759 - $704,387	-11,783 Reduced 19.97%	47,230 $1.28 Million
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $722,660 - $1.01 Million	16,552 Added 38.98%	59,013 $3.18 Million
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $11,124 - $29,857	386 Added 0.92%	42,461 $1.71 Million
Q1 2022 May 04, 2022	SELL	$48.25 - $100.49 $714,630 - $1.49 Million	-14,811 Reduced 26.04%	42,075 $2.79 Million
Q4 2021 Feb 04, 2022	SELL	$88.71 - $120.43 $1.33 Million - $1.8 Million	-14,939 Reduced 20.8%	56,886 $5.69 Million
Q3 2021 Oct 07, 2021	BUY	$98.77 - $132.17 $353,102 - $472,507	3,575 Added 5.24%	71,825 $8.98 Million
Q2 2021 Aug 04, 2021	BUY	$109.77 - $165.68 $319,650 - $482,460	2,912 Added 4.46%	68,250 $8.48 Million
Q1 2021 May 04, 2021	BUY	$127.04 - $179.1 $1.34 Million - $1.89 Million	10,537 Added 19.23%	65,338 $9.97 Million
Q4 2020 Feb 02, 2021	BUY	$99.96 - $135.93 $767,592 - $1.04 Million	7,679 Added 16.3%	54,801 $7.06 Million
Q3 2020 Oct 09, 2020	BUY	$80.32 - $111.8 $45,621 - $63,502	568 Added 1.22%	47,122 $5.27 Million
Q2 2020 Jul 08, 2020	BUY	$60.49 - $97.5 $136,828 - $220,545	2,262 Added 5.11%	46,554 $3.78 Million
Q1 2020 Apr 23, 2020	BUY	$59.04 - $88.81 $2.4 Million - $3.6 Million	40,582 Added 1093.85%	44,292 $3.08 Million
Q4 2019 Feb 11, 2020	SELL	$59.49 - $82.78 $21,654 - $30,131	-364 Reduced 8.93%	3,710 $290,000
Q3 2019 Oct 17, 2019	BUY	$62.59 - $110.3 $254,991 - $449,362	4,074 New	4,074 $260,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Guardant Health, Inc. Transaction History